Recombinant Human GDF15 Protein，His

GDF15, or Growth Differentiation Factor 15, is a member of the transforming growth factor-beta (TGF-β) superfamily and plays a critical role in various physiological and pathological processes, including inflammation, metabolism, and cellular stress response. Elevated levels of GDF15 have been associated with several diseases, including cardiovascular conditions, cancer, and metabolic disorders, making it a biomarker of interest for disease diagnosis and prognosis. Research has revealed that GDF15 is produced in response to stressors such as injury or inflammation, influencing cellular communication and adaptation. The recombinant protein form of GDF15 facilitates detailed studies into its biological functions, signaling pathways, and potential therapeutic applications. By using the recombinant protein, researchers can analyze the specific interactions of GDF15 with its receptors and downstream signaling molecules, providing insights into its role in various disease states. Additionally, recombinant GDF15 is being explored for its potential as a therapeutic agent, offering possibilities for developing treatments that modulate its expression or activity to mitigate disease progression. Understanding the mechanisms by which GDF15 exerts its effects may lead to novel therapeutic strategies in managing conditions where its dysregulation is involved. This line of research holds promise for enhancing our knowledge of GDF15 and its implications in health and disease, establishing it as a key player in the intersection of metabolic and inflammatory pathways.